Bank of Nova Scotia’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.49M Sell
15,203
-45,572
-75% -$7.01M ﹤0.01% 707
2025
Q4
$10.6M Sell
60,775
-445,470
-88% -$81.3M 0.02% 465
2025
Q3
$72.9M Buy
+506,245
New +$62M 0.13% 129

Other funds holding INSM

Bank of Nova Scotia's INSM Position: Q1 2026 in Review

Bank of Nova Scotia reduced its Insmed (INSM) stake by 75% in Q1 2026, selling an estimated $7.01M and leaving 15,203 shares worth $2.49M. The position accounts for ﹤0.01% of the portfolio, ranked #707.

Bank of Nova Scotia first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. The position peaked at $72.9M in Q3 2025. 670 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Bank of Nova Scotia held 15,203 shares of Insmed worth $2.49M as of Q1 2026.
  • Bank of Nova Scotia sold 45,572 Insmed shares in Q1 2026, an estimated $7.01M.
  • Insmed made up ﹤0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #707 holding.
  • Bank of Nova Scotia first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
  • Bank of Nova Scotia's Insmed position peaked at $72.9M in Q3 2025.
  • 670 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.